I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase 1/2 trial of glasdegib in patients with primary or se..:
Gerds, Aaron T
;
Tauchi, Tetsuzo
;
Ritchie, Ellen
...
qt1s54w00c. , 2019
Link:
https://escholarship.org/uc/item/1s54w00c
RT Journal T1
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt1s54w00c&Exemplar=1&LAN=DE A1 Gerds, Aaron T A1 Tauchi, Tetsuzo A1 Ritchie, Ellen A1 Deininger, Michael A1 Jamieson, Catriona A1 Mesa, Ruben A1 Heaney, Mark A1 Komatsu, Norio A1 Minami, Hironobu A1 Su, Yun A1 Shaik, Naveed A1 Zhang, Xiaoxi A1 DiRienzo, Christine A1 Zeremski, Mirjana A1 Chan, Geoffrey A1 Talpaz, Moshe PB eScholarship, University of California YR 2019 K1 Brain Disorders K1 Clinical Research K1 Evaluation of treatments and therapeutic interventions K1 6.1 Pharmaceuticals K1 Adolescent K1 Adult K1 Aged K1 80 and over K1 Benzimidazoles K1 Chemotherapy K1 Adjuvant K1 Female K1 Humans K1 Male K1 Middle Aged K1 Nitriles K1 Organ Size K1 Phenylurea Compounds K1 Primary Myelofibrosis K1 Pyrazoles K1 Pyrimidines K1 Spleen K1 Treatment Outcome K1 Young Adult K1 Glasdegib K1 Hedgehog inhibitor K1 Smoothened inhibitor K1 Myelofibrosis K1 Clinical Sciences K1 Immunology JF qt1s54w00c LK http://dx.doi.org/https://escholarship.org/uc/item/1s54w00c DO https://escholarship.org/uc/item/1s54w00c SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)